A Food and Drug Administration (FDA) analysis of recalled lots of Medisca’s L-citrulline, a drug used to treat certain urea cycle disorders, a rare genetic disorder primarily diagnosed in children, revealed that the samples contained N-acetyl-leucine, a product used to treat a certain type of dizziness known as acute vestibular vertigo. No L- citrulline was found in the samples tested by the FDA. The recall was initiated last week after the FDA received reports of adverse events associated with subpotent L-citrulliine in patients who were administered the drug. Subpotent L-citurlline in patients with certain urea cycle defects can lead to high ammonia ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.